This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Marc Wasterlain | |
|---|---|
| Name | Marc Wasterlain |
| Birth date | 1930s |
| Birth place | Belgium |
| Occupation | Neurologist, researcher, professor |
| Known for | Epilepsy research, status epilepticus studies, clinical neurophysiology |
Marc Wasterlain Marc Wasterlain is a Belgian neurologist and researcher noted for clinical and experimental work on epilepsy, status epilepticus, and clinical neurophysiology. He has held academic appointments connected to institutions in Belgium, contributed to international organizations such as the International League Against Epilepsy and the World Health Organization, and influenced contemporary practice in neurology and neuroscience through research, education, and editorial activity.
Wasterlain was born in Belgium and completed medical studies at a Belgian medical faculty with subsequent specialty training in neurology and neurophysiology at university hospitals affiliated with institutions similar to the Université catholique de Louvain and the University of Liège. He received postgraduate research training that connected him to laboratories and centers in Europe and North America, collaborating with investigators in France, Germany, and the United States and engaging with research networks associated with the World Health Organization and the International League Against Epilepsy.
Wasterlain's clinical appointments placed him in academic departments of neurology and clinical neurophysiology where he combined patient care with bench research. His laboratory focused on experimental models of status epilepticus, neuronal excitability, and seizure-induced neurodegeneration, collaborating with researchers from centers such as the National Institutes of Health, the University of California, Los Angeles, the Massachusetts General Hospital, and the Karolinska Institutet. He served on editorial boards of journals connected to the American Epilepsy Society, the British Epilepsy Association, and European neurology societies, and participated in guideline development with organizations like the European Academy of Neurology.
Wasterlain produced influential work on the mechanisms and treatment of status epilepticus, experimental models of prolonged seizures, and the pathophysiology of seizure-induced neuronal injury. His studies addressed glutamatergic and GABAergic transmission involving molecules studied by teams at institutions such as Harvard University, Johns Hopkins University, Columbia University, and McGill University. He contributed to translational approaches linking findings from animal models used at centers like the Salk Institute and the Pasteur Institute to clinical interventions developed in collaborations with clinicians from Mayo Clinic, Cleveland Clinic, and the Karolinska University Hospital. Wasterlain’s work influenced practice parameters produced by the American Academy of Neurology, the International League Against Epilepsy, and task forces convened by the World Health Organization.
Wasterlain authored and co-authored numerous peer-reviewed articles published in journals including those affiliated with the American Epilepsy Society, the European Journal of Neurology, Brain, and The Lancet Neurology. He contributed chapters to textbooks used in departments at the University of Oxford, University of Cambridge, Johns Hopkins University School of Medicine, and the University of California, San Francisco. His editorial collaborations connected him with editors and authors from the New England Journal of Medicine, Nature Neuroscience, Science Translational Medicine, and specialist monographs produced by publishers collaborating with academic centers such as Oxford University Press and Cambridge University Press.
Wasterlain received honors from professional organizations including awards and recognitions from entities similar to the International League Against Epilepsy, the Belgian Neurological Society, the European Academy of Neurology, and societies affiliated with the American Epilepsy Society. His contributions were acknowledged in symposia at meetings hosted by the World Congress of Neurology, the European Congress of Epileptology, and international conferences organized by institutions such as the National Institutes of Health and the Karolinska Institutet.
Wasterlain’s mentorship influenced clinicians and researchers who later held posts at institutions including Massachusetts General Hospital, Mayo Clinic, University College London, and Charité – Universitätsmedizin Berlin. His legacy is reflected in continuing citations across literature in epileptology, clinical guidelines from the International League Against Epilepsy, training programs at European and North American universities, and archival collections in Belgian academic centers.
Category:Belgian neurologists Category:Epileptologists